Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Clin Endocrinol (Oxf). 2022 Apr 27;98(1):32–40. doi: 10.1111/cen.14743

Table 2.

Individual data of patients with cystic pheochromocytoma

Patient indicator Demographics and presentation Catecholamine excess Imaging presentation
Age Sex Symptoms Fold increment > upper normal range Maximum tumor size, cm Cystic volume, % Solid volume, % Unenhanced HU cystic component Unenhanced HU solid component
A 42 F Yes >10 11.2 75 25 30 48
B 50 F No >10 9.1 77 23 30 50
C 56 M Yes >10 11.7 68 32 14 39
D 59 F Yes 5–10 4.1 26 74 N/A N/A
E 55 M Yes >10 8.2 50 50 20 46
F 63 M No <5 2.9 15 85 19 29
G 66 M No 5–10 3.8 24 76 13 45
H 57 M Yes N/A 18.9 40 60 18 35
I 75 M No 5–10 6.4 53 47 14 34
J 76 F Yes >10 5 49 51 17 42
K 69 F No <5 12 64 36 N/A N/A
L 55 F Yes >10 8.2 28 72 17 43
M 86 M No <5 5.5 44 56 18 28
N 52 F Yes >10 6.5 29 71 N/A N/A
O 65 F No 5–10 4.4 24 76 17 32
P 4 M Yes >10 5 24 76 27 41
Q 49 M Yes >10 13.5 23 77 17 34
R 68 F Yes 5–10 6.3 25 75 N/A N/A
S 65 F No >10 14.9 22 78 20 44
T 54 F Yes <5 5.7 56 44 14 22
U 41 F Yes >10 6.3 70 30 N/A N/A

Abbreviations – F: Female, HU: Hounsfield Unit, M: Male, N/A: Not available